Broadband iTV designs, executes, and manages interactive television applications. Using BBiTV’s plug-and-play technology, cable operators can establish an interactive community channel on their system quickly and easily. This channel enables community members to use television in a way they never have before—to communicate among themselves, to build stronger interactions between community groups, and to buy and sell goods and services directly with one another.
Umbel is a customer data platform that empowers companies to unify and access their own customer data. Powered by its patented Digital Genome®, Umbel brings together data cross silos and marketing execution systems into one unified, beautiful and actionable platform. Umbel makes data accessible to non-database experts in an organization and is able to speed existing IT investments by creating fast feedback loops and lower computing thresholds. Umbel makes it easy and visual to query, extract, transfer and load data within a unified or non-unified technology stack.
BioHitech provides a simple, environmentally friendly, and cost-effective solution for food waste disposal. BioHiTech is using technology to open new opportunities in an industry that has gone unchanged for almost 50 years. BioHiTech offers customers a more cost-effective and technologically innovative solution compared to traditional disposal. This approach will help reduce the generation of waste as well as reduce costs and increase recycling rates. BioHitech has a global distribution license to sell, lease, use, distribute, and manufacture the product currently known as the Eco-Safe Digester. Recognizing that the traditional waste management industry has remained relatively resistant to adoption of emerging technologies and has been reluctant to provide consumers with transparency of their waste streams, BioHitech America has improved on its Eco-Safe Digester with the addition of a new, data-driven management tool (BioHitech Cloud).
Super League Gaming
Super League Gaming’s mission is to give gamers an entirely new way to enjoy the games they love. The Santa Monica-based company cut its teeth producing Minecraft events nationwide, an event series that continues to grow. Never content thinking small, Super League Gaming goes big. Its competitions take place in state-of-the-art movie theaters. All the action is played out on big screens and bolstered with thundering sound systems. In partnership with Riot Games, Super League Gaming is now readying City Champs and City Rec League of Legends events which offer players new ways to compete, learn, socialize and have fun playing their favorite games in a local league.
Liquidmetal is a revolutionary material technology discovered in conjunction with NASA. Considered one of the their top discoveries, it has the potential to fundamentally change the paradigm in material science. Liquidmetal harness this technology to produce the world’s leading wear and corrosion solutions. Liquidmetal Coatings is an industry leader in the development of amorphous alloy solutions for wear and corrosion and holds a portfolio of technology patents. The Company’s proprietary line of amorphous alloys are deployed as the top performing solutions to wear and corrosion in many industries including: Oil & Gas, Power Generation, Pulp & Paper, Mining and others, where extensive use or corrosion can cause higher maintenance costs, increased replacement costs and/or preventable downtime costs. Liquidmetal derives its revenue from its Materials, Services and Products Groups with a recurring customer base of over 100 global companies buying products and services. Many of Liquidmetal’s customers are long standing and have purchased products from Liquidmetal consistently in each of the last 10 years.
Ensysce Biosciences is an integrated drug delivery company with two proprietary, novel platforms for the pain and cancer markets. The Company's near term clinical program initiated in early 2016 for PF614. PF614 with BIO-MD™ technology was developed to prevent abuse of oxycodone, a pain medicine with $2.8 billion in annual sales,. Ensysce’s SWCNT technology is poised to transform delivery of large biomolecules. Ensysce's BIO-MD™ platform is a proprietary abuse-resistant opioid prodrug technology that has broad potential to address the concurrent challenges of treating patients with chronic pain while reducing prescription opioid abuse. The BIO-MD™ platform eliminates a patients’ ability to abuse prescription medicines by the non-oral route. The company’s extensive portfolio of BIO-MD™ products provides the company with numerous partnership and co-development opportunities. Ensysce has created single-walled carbon nanotubes (SWCNT) for delivery of large biomolecules. Based on the pioneering work of the late Nobel Prize winner Dr. Richard Smalley, SWCNT have the potential to provide intravenously delivered immune and gene therapies.
Precipio Diagnostics is a fully-established, operating diagnostics company that has successfully processed over 2000 patient cases from over 60 customers. Precipio is the only diagnostics company to address the challenges of disease misdiagnosis and bring a solution to the clinical world. Precipio has successfully combined the experience, knowledge and expertise of academic-level pathology, with commercial-level service. The Company has exclusive contracts with Yale University and the University of Pennsylvania's Pathology Labs. Physicians around the world benefit from direct access to the highest quality of diagnostic support, coupled with rapid and efficient service, needed to battle cancer. Precipio offers an ethical approach that places the patient’s care first, above economic interests. Using a proprietary algorithmic approach to match disease symptoms with testing modalities, Precipio achieves a higher level of diagnostic accuracy, which benefits the patient, the physician, and maximizes return on healthcare dollars spent. Through collaborations with world-class academic institutions specializing in cancer research, diagnostics & treatment, and the Company's experience delivering quality service - Precipio offers a new standard of diagnostic accuracy, service & support, and the highest level of care to patients.
Transgenomic, Inc. is a global biotechnology company advancing personalized medicine in oncology and inherited diseases through advanced diagnostic technologies, such as its revolutionary ICE COLD-PCR, which enables use of liquid biopsies for mutation detection. The company also provides specialized clinical and research services to biopharmaceutical companies developing targeted therapies. Transgenomic’s diagnostic technologies are designed to improve medical diagnoses and patient outcomes.
WaveTech specializes in the development of technologies for the targeted manipulation of crystallization formations within fluid media. WaveTech’s Crystal Control Technology® technique deploys disruptive static and dynamic electrical fields to prevent or to stimulate crystal growth. The energy derived from these electrical fields controls the interaction between the ions in liquid(s) and the ions on the surface of the electrode(s) immersed in the liquid. WaveTech produces highly competitive products that can be used in products where crystal formation plays an important role. The applications of WaveTech’s CCT® in commercial product lines are numerous for both industrial and domestic use. This technology can, for example, be used to alter the molecular structures of crystal formations at the electrodes in a lead-acid battery. WaveTech’s patented Crystal Control Technology® addresses the problem of battery waste and high replacement costs by effectively renewing the active material within batteries. CCT® manipulates crystal formation on the electrodes to double battery life and triple the lifecycle capacity. The Company has taken the next step in product evolution with its BEAT (Battery Enhancement And Treatment) product line. This acronym also refers to a “heartbeat” or “pulse”, which is how WaveTech’s products deliver its Crystal Control Technology®; via electric pulses that are sent through the battery when the BEAT® is active. The essence of the BEAT® product line is now caught in a printed circuit board/microchip circuitry that is integrated into the battery lid. This has the advantage that it hardly interferes with the battery manufacturing process. Battery producers can either purchase the lid with CCT® inside or license the technology to manufacture their own lids. This provides a new generation of batteries for multiple applications.